| ISPOR Symposia/Conferences |
| Rising Cost of Drug Coverage and Limited Healthcare Budgets: A Search for Solutions (September 1999) |
| LIPID Conference: Pharmacoeconomics & Outcomes Issues of Lipid Therapy - Abstracts (November 1997) |
| |
| ISPOR / PhRMA Co-sponsored Symposia |
As the HTA World Turns: What’s on the Horizon
ISPOR / PhRMA Co-sponsored Symposium (May 2009, Orlando, FL, USA) |
Evolving Evidence Requirements in the Changing Global Landscape of Payer-Decision Making
ISPOR / PhRMA Co-sponsored Symposium
(May 2008, Toronto, ON, Canada) |
Health Care Comparative Effectiveness in the United States - Symposium
ISPOR / PhRMA Co-sponsored Symposium (May 2007, Arlington, VA, USA) |
Evidence Based Medicine: What Does It Mean? How Should Real World Evidence Be Used In Healthcare Decisions? What Is The Future?
ISPOR / PhRMA Co-sponsored Symposium (May 2006, Philadelphia, USA) |
The Evolution and Innovation of Pharmaceutical Technology: Implications for US Medicare Modernization Act
ISPOR / PhRMA Co-sponsored Symposium (May 2005, Arlington, VA, USA) |
Benefit/Risk: In Search of the Proper Balance
ISPOR / PhRMA Co-sponsored Symposium (May 2004, USA) |
The Evolution and Innovation of Pharmaceutical Technology: Implications for US Medicare Modernization Act
ISPOR / PhRMA Co-sponsored Symposium (May 2003, Arlington, VA, USA) |
Patient-Reported Outcomes "Pro" Symposium: Conceptual And Methodological Issues
ISPOR / PhRMA Co-sponsored Symposium (May 2002, USA) |
NICE To Know: An Update on the National Institute for Clinical Excellence Guidelines - Symposium
ISPOR / PhRMA Co-sponsored Symposium (May 2001) |
Quality of Life Promotional Claims: Methodological Issues and Potential Solutions Symposium
ISPOR / PhRMA Co-sponsored Symposium (May 2000, Arlington, VA, USA) |
| |
| Sponsored Symposia at ISPOR Meetings |
The 7 Essentials of Successful Health Economic Communication
Sponsored by Medaxial (May 2010, Atlanta, GA, USA) |
Will Comparative Effectiveness Research Survive Health Reform?
Sponsored by IMS (May 2010, Atlanta, GA, USA) |
Performance-Based Risk Sharing Agreements: Fad or Trend?
Sponsored by RTI Health Solutions (May 2010, Atlanta, GA, USA) |
Comparative Effectiveness & Standards of Evidence: The Intersection of Science, Policy, Regulation, and Business
Sponsored by UBC (May 2010, Atlanta, GA, USA) |
Regulatory Review and Health Technology Assessment (HTA) - Opportunities and Limitations of an Integrative Approach
Sponsored by European Federation of Pharmaceutical Industries and Associations (EFPIA) (October 2009, Paris, France) |
Comparative Effectiveness: Can the Agencies' Demands Be Met?
Sponsored by UBC and Shire (October 2009, Paris, France) |
New Developments in Health Technology Assessment (HTA): How does this Impact Health Economics and Outcomes Research
Sponsored by IMS (October 2009, Paris, France) |
Models For Reimbursement for Oncology Products in Latin American Countries: The Perspective of Brazil, Colombia, and Mexico
Sponsored by Pfizer (September 2009, Rio de Janeiro, Brazil) |
Using Health Economics and Outcomes Research for health care decision making –
the case of Latin America in the context of global trends in HTA
Sponsored by IMS (September 2009, Rio de Janeiro, Brazil) |
Learnings and Application To Health Technology Assessment in Latin America - Structural Components, Operational Issues, and Technical Considerations
Sponsored by Lilly (September 2009, Rio de Janeiro, Brazil) |
Value of Vaccination: Time to Wake-Up!
Sponsored by Sanofi-Pasteur (September 2009, Rio de Janeiro, Brazil) |
Reimbursment Review Process Across Latin America
Sponsored by Millcreek Outcomes Group, LLC (September 2009, Rio de Janeiro, Brazil) |
Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries
Sponsored by Oxford Outcomes, National Pharmaceutical Council, and Shire (May 2009, Orlando, FL, USA) |
Innovation in the Measurement of Health-Related Quality of Life: The EQ-5D R&D Programme
Sponsored by EuroQol Group (May 2009, Orlando, FL, USA) |
The Comparative Effectiveness Research Wave: Solving Surfing Techniques
Sponsored by UBC (May 2009, Orlando, FL, USA) |
Striving Towards a New Value Equation: The Need to Integrate Pricing & Reimbursement and Health Economics & Outcomes Research to Support Various Stakeholders in
Improving Health Care Systems
Sponsored by IMS (May 2009, Orlando, FL, USA) |
Once Upon a Time in Health Economics… Narrative vs. Analysis in Communicating
Product Value
Sponsored by Medaxial (May 2009, Orlando, FL, USA) |
Healthcare Modeling: Simulation Modeling in Intervention Prioritization
Sponsored by Archimedes (May 2009, Orlando, FL, USA) |
Personalized Medicine and Targeted Therapy - Who Will Pay for Advances in Cancer Care?
Sponsored by i3 Innovus (November 2008, Athens, Greece) |
The Do’s and Don’ts with Agencies like NICE or IQWiG – Generating the Right Health Economic Data for Successful Appraisals
Symposium sponsored by NHS Innovations London (November 2008, Athens, Greece) |
Finding Synergies between Pricing & Reimbursement and Health Economics and Outcomes Research
Symposium Sponsored by IMS Health (November 2008, Athens, Greece) |
Risk-sharing Agreements: All Pain or Some Gain?
Symposium sponsored by UBC (November 2008, Athens, Greece) |
Achieving Better Health Outcomes For The Benefit Of Patients - An Update On EFPIA's Key HTA Principles
Symposium sponsored by EFPIA (November 2008, Athens, Greece) |
Why Does Medication Noncompliance Persist?
Multiple Stakeholders Chart a Research Agenda for the 21st Century
IMS Health Symposium (May 2008, Toronto, ON, Canada)
|
Prevention of Cardiovascular Disease in the Medicare Population
Symposium sponsored by Archimedes (May 2008, Toronto, ON, Canada) |
Obtaining a Patient-Reported Outcomes Label Claim: What Evidence Do You Need?
RTI Health Solutions Symposium (May 2008, Toronto, ON, Canada) |
Can You Hear Me Now? Techniques for effectively communicating value to internal and external decision makers.
Symposium Sponsored by IMS Health (October 2007, Dublin, Ireland) |
Can We Afford to Pay for Innovation? How to balance delivering cost-effective health care, maximizing health, and stimulating continued research and development
Symposium sponsored by i3 Innovus (October 2007, Dublin, Ireland) |
Raising the Bar in the U.S.: The Impact of Heightened Awareness of the Need for Health-Economic Data in the Absence of a Regulatory Mandate
Symposium Sponsored by IMS Health (May 2007, Arlington, VA, USA)
|
The Impact Of Compliance And Persistence On The Economics And Outcomes Of Hypertension
A Millcreek Outcomes Group and Novartis Symposium (October 2006, Copenhagen, Denmark) |
The Increasing Need For Real-Life Data In Observational Studies Throughout The Product Life Cycle
Symposium Sponsored by IMS Health (October 2006, Copenhagen, Denmark) |
Handling Issues Around Missing Data In Economic Analysis
Symposium Sponsored by IMS Health (May 2006, Philadelphia, PA, USA) |
Transferring Health Economic Methods and Results from One Country To Another: Issues and Possible Solutions.
IMS Health Symposium (November 2005, Florence, Italy) |
Methodological Issues in the Analysis of Health Care Databases
Symposium Sponsored by IMS Health (May 2005, Washington, DC, USA) |
Clinical & Social Burden Of COPD
Symposium sponsored by Pfizer Pharmaceuticals Inc. and Nippon Boehringer-Ingelheim Co. Ltd. (September 2003, Kobe, Japan) |
|